Kartman B - Search Results

1

A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus.

Kayaniyil S, Lozano-Ortega G, Bennett HA, Johnsson K, Shaunik A, Grandy S, Kartman B. Kayaniyil S, et al. Among authors: kartman b. Diabetes Ther. 2016 Mar;7(1):27-43. doi: 10.1007/s13300-016-0155-1. Epub 2016 Feb 17. Diabetes Ther. 2016. PMID: 26886440 Free PMC article. Review.

2

Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective.

Chuang LH, Verheggen BG, Charokopou M, Gibson D, Grandy S, Kartman B. Chuang LH, et al. Among authors: kartman b. J Med Econ. 2016 Dec;19(12):1127-1134. doi: 10.1080/13696998.2016.1203329. Epub 2016 Jun 28. J Med Econ. 2016. PMID: 27310712 Free article.

3

Multivariate Prediction Equations for HbA_1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling.

Willis M, Asseburg C, Nilsson A, Johnsson K, Kartman B. Willis M, et al. Among authors: kartman b. Value Health. 2017 Mar;20(3):357-371. doi: 10.1016/j.jval.2016.10.004. Epub 2016 Dec 1. Value Health. 2017. PMID: 28292480 Free article.

4

Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

Reed SD, Li Y, Dakin HA, Becker F, Leal J, Gustavson SM, Kartman B, Wittbrodt E, Mentz RJ, Pagidipati NJ, Bethel MA, Gray AM, Holman RR, Hernandez AF; EXSCEL Study Group. Reed SD, et al. Among authors: kartman b. Diabetes Care. 2020 Feb;43(2):374-381. doi: 10.2337/dc19-0950. Epub 2019 Dec 5. Diabetes Care. 2020. PMID: 31806653 Free PMC article. Clinical Trial.

5

The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes.

Gordon J, McEwan P, Sabale U, Kartman B, Wolffenbuttel BH. Gordon J, et al. Among authors: kartman b. J Med Econ. 2016 Dec;19(12):1167-1174. doi: 10.1080/13696998.2016.1208207. Epub 2016 Aug 9. J Med Econ. 2016. PMID: 27356188 Free article.

6

The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes - An Analysis From The Swedish Health Care Perspective.

Gordon J, McEwan P, Sabale U, Kartman B. Gordon J, et al. Among authors: kartman b. Value Health. 2014 Nov;17(7):A344. doi: 10.1016/j.jval.2014.08.693. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200645 Free article. No abstract available.

7

Cost implications of development of diabetes in the ALPINE study.

Lindholm LH, Kartman B, Carlberg B, Persson M, Svensson A, Samuelsson O. Lindholm LH, et al. Among authors: kartman b. J Hypertens Suppl. 2006 Mar;24(1):S65-72. doi: 10.1097/01.hjh.0000220409.69116.2e. J Hypertens Suppl. 2006. PMID: 16601576 Clinical Trial.

8

A multinational investigation of time and traveling costs in attending anticoagulation clinics.

Jowett S, Bryan S, Mahé I, Brieger D, Carlsson J, Kartman B, Nevinson M. Jowett S, et al. Among authors: kartman b. Value Health. 2008 Mar-Apr;11(2):207-12. doi: 10.1111/j.1524-4733.2007.00253.x. Value Health. 2008. PMID: 18380632 Free article. Clinical Trial.

9

Valuation of health changes with the contingent valuation method: a test of scope and question order effects.

Kartman B, Stålhammar NO, Johannesson M. Kartman B, et al. Health Econ. 1996 Nov-Dec;5(6):531-41. doi: 10.1002/(SICI)1099-1050(199611)5:6<531::AID-HEC235>3.0.CO;2-J. Health Econ. 1996. PMID: 9003940

10

The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly.

Lundkvist J, Ekman M, Kartman B, Carlsson J, Jönsson L, Lithell H. Lundkvist J, et al. Among authors: kartman b. J Hum Hypertens. 2005 Jul;19(7):569-76. doi: 10.1038/sj.jhh.1001857. J Hum Hypertens. 2005. PMID: 15800664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page